From the Journals

Frequent visits to green spaces linked to lower use of some meds


 

Evidence mounts on the benefits of nature

There is growing evidence that exposure to nature could benefit human health, especially mental and cardiovascular health, says Jochem Klompmaker, PhD, a postdoctoral researcher in the department of environmental health at the Harvard T.H. Chan School of Public Health, Boston.

Dr. Klompmaker has researched the association between exposure to green spaces and health outcomes related to neurological diseases.

In a study recently published in JAMA Network Open, and reported by this news organization, Dr. Klompmaker and his team found that among a large cohort of about 6.7 million fee-for-service Medicare beneficiaries in the United States aged 65 or older, living in areas rich with greenery, parks, and waterways was associated with fewer hospitalizations for certain neurological disorders, including Parkinson’s disease, Alzheimer’s disease, and related dementias.

Commenting on the current study, Dr. Klompmaker noted its strengths.

“A particular strength of this study is that they used data about the amount of green and blue spaces around the residential addresses of the participants, data about green space visit frequency, and data about green and blue views from home. Most other studies only have data about the amount of green and blue spaces in general,” he said.

“The strong protective associations of frequency of green space visits make sense to me and indicate the importance of one’s actual nature exposure,” he added. “Like the results of our study, these results provide clinicians with more evidence of the importance of being close to nature and of encouraging patients to take more walks. If they live near a park, that could be a good place to be more physically active and reduce stress levels.”

The study was supported by the Academy of Finland and the Ministry of the Environment. Dr. Turunen and Dr. Klompmaker report no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

PPI use in type 2 diabetes links with cardiovascular events
Journal of Clinical Outcomes Management
Does EPA lower CV risk? REDUCE-IT revisited
Journal of Clinical Outcomes Management
A remote mountain bike crash forces a doctor to take knife in hand
Journal of Clinical Outcomes Management
Possible bivalent vaccine link to strokes in people over 65
Journal of Clinical Outcomes Management
Size of meals, not timing, linked to weight loss
Journal of Clinical Outcomes Management
AHA scientific statement on rapid evaluation for suspected TIA
Journal of Clinical Outcomes Management
More type 2 diabetes deaths from cancer than heart disease
Journal of Clinical Outcomes Management
Angioedema risk jumps when switching HF meds
Journal of Clinical Outcomes Management
Long QT syndrome overdiagnosis persists
Journal of Clinical Outcomes Management
CV deaths jumped in 2020, reflecting pandemic toll
Journal of Clinical Outcomes Management